David Bernhard

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

Astrid A. Ruefli, Michael J. Ausserlechner, David Bernhard et al. · Proceedings of the National Academy of Sciences · 2001 · 489 citations · Full text

Histone Deacetylase Inhibitor, Apoptosis, Cell Death +16

Cadmium Is a Novel and Independent Risk Factor for Early Atherosclerosis Mechanisms and In Vivo Relevance

Michael Knoflach, Andreas Seubert, Andreas Ritsch et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 316 citations · Full text

Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease

Garland Anderson, Ali Reza Noorian, George T. Taylor et al. · Experimental Neurology · 2007 · 235 citations · Full text

Functional Gastrointestinal Disorder, Colon Motility, Physiology +9

Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis

Mechthild Wagner, Barbara Hampel, David Bernhard et al. · Experimental Gerontology · 2001 · 198 citations

Replicative Senescence, Developmental Biology, Aging +8

Resveratrol, a tumor‐suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl‐2

Inge Tinhofer, David Bernhard, Monika Senfter et al. · The FASEB Journal · 2001 · 182 citations